ECSP003724A - ORAL FORMULATIONS FOR ANTI-TUMOR COMPOUNDS - Google Patents
ORAL FORMULATIONS FOR ANTI-TUMOR COMPOUNDSInfo
- Publication number
- ECSP003724A ECSP003724A ECSP003724A ECSP003724A EC SP003724 A ECSP003724 A EC SP003724A EC SP003724 A ECSP003724 A EC SP003724A EC SP003724 A ECSP003724 A EC SP003724A
- Authority
- EC
- Ecuador
- Prior art keywords
- oral formulations
- tumor compounds
- pharmaceutically acceptable
- polyglocolized
- camotothecin
- Prior art date
Links
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 125000005456 glyceride group Chemical group 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
- 230000008719 thickening Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a un medio de relleno semi-sólido que comprende un derivado de camtotecina; una matriz de vehículo farmacéuticamente aceptable que es un glicérido poliglocolizado; y una cantidad efectiva que reduce el espesamiento y promueve la estabilización de uno o más excipientes farmacéuticamente aceptables.The present invention relates to a semi-solid filler medium comprising a camotothecin derivative; a pharmaceutically acceptable carrier matrix that is a polyglocolized glyceride; and an effective amount that reduces thickening and promotes stabilization of one or more pharmaceutically acceptable excipients.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003724 ECSP003724A (en) | 2000-10-19 | 2000-10-19 | ORAL FORMULATIONS FOR ANTI-TUMOR COMPOUNDS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003724 ECSP003724A (en) | 2000-10-19 | 2000-10-19 | ORAL FORMULATIONS FOR ANTI-TUMOR COMPOUNDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003724A true ECSP003724A (en) | 2000-12-19 |
Family
ID=42041303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003724 ECSP003724A (en) | 2000-10-19 | 2000-10-19 | ORAL FORMULATIONS FOR ANTI-TUMOR COMPOUNDS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003724A (en) |
-
2000
- 2000-10-19 EC ECSP003724 patent/ECSP003724A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY138106A (en) | Oral fomulations for anti-tumor compounds | |
| PA8523201A1 (en) | NEW PHARMACEUTICAL COMPOSITION | |
| GT199800101A (en) | SOLID PHARMACEUTICAL COMPOSITION CONTAINING A DERIVATIVE OF BENZOFURANE. | |
| UY27586A1 (en) | CIS- IMIDAXOLINAS | |
| CO4900033A1 (en) | METALOPROTEASE INHIBITING COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| EP1401479A4 (en) | DETECTION AND THERAPY OF VULNERABLE PLATES USING PHOTODYNAMIC COMPOUNDS | |
| GT200000005A (en) | USEFUL REPLACED BICYCLE DERIVATIVES AS AGENTS AGAINST CANCER. | |
| TNSN01130A1 (en) | EXTENDED RELEASE FORMULATIONS FOR GROWTH HORMONE SECRETAGOGUES | |
| CO4920240A1 (en) | DIHETERO-CYCLIC METALOPROTEASE INHIBITOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS FOR ITS USE | |
| CO4920242A1 (en) | METALOPREOTEASE INHIBITING COMPOUNDS 1,4-HETEROCICLICOS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS FOR ITS USE | |
| CO4900035A1 (en) | METALOPROTEASE INHIBITING COMPOUNDS 1,3-DIHETEROCICLICOS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS FOR USE | |
| EA200100298A1 (en) | PHARMACEUTICAL PREPARATIONS WITH ADJUSTABLE LIBERATION CONTAINING THE INHIBITOR OF cGMP-PHOSPHODYSTRASE-5 | |
| NO20043367L (en) | Oral pharmaceutical preparation | |
| PA8581801A1 (en) | FORMULATIONS CONTAINING AN INDOLINONE COMPOUND | |
| IL208697A0 (en) | Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol | |
| MX9306196A (en) | NEW CRYSTAL FORM POLYMORPH OF TERAZOSINE AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT. | |
| PA8495101A1 (en) | DERIVATIVES OF 13-METHYLERITROMYCIN | |
| LU91251I2 (en) | Rotavirus vaccine (live) and its pharmaceutically acceptable derivatives (ROTARIXr) | |
| CO4900045A1 (en) | SPYROCYCLIC METALOPROTEASE INHIBITING COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS FOR ITS USE | |
| PL361061A1 (en) | Crystalline forms of fluvastatin sodium | |
| EP1142573A4 (en) | ANTIBACTERIAL MEDICAL COMPILATION | |
| ES2170143T3 (en) | COMPOSITIONS THAT INCLUDE HALOFANTRINE IN A SPECIAL FORM. | |
| SV1996000040A (en) | PHARMACEUTICAL COMPOSITIONS REF. 14862SV | |
| ES2181052T3 (en) | PHENYLACETAMIDS AS INHIBITORS OF SPLA2. | |
| ES2150404T1 (en) | PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDE AND NITOZOXANIDE. |